GNH USA

Europe — EMA

Orfiril (Sodium Valproate)

GNH USA supplies Orfiril (Sodium Valproate), a antiepileptic for epilepsy, bipolar disorder and migraine prophylaxis. Request a quote for global supply.

Sodium Valproate

Request sourcing

1
Pack/s

What is Sodium Valproate?

Sodium Valproate, the active ingredient in Orfiril, is a anticonvulsant presented as an oral tablet for oral use. It treats epilepsy, bipolar disorder, and migraine prophylaxis in adults and children as prescribed by a physician.

GNH USA supplies Orfiril as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Sodium Valproate used for?

Orfiril, a sodium valproate product, acts on neuronal excitability and is used for several neurological and psychiatric conditions. - Epilepsy: reduces seizure frequency and severity. - Bipolar disorder: stabilizes mood and prevents manic episodes. - Migraine prophylaxis: decreases the number of migraine attacks.

What are the side effects of Sodium Valproate?

Common Side Effects: - Nausea or abdominal discomfort. - Tremor or mild muscle weakness. - Weight gain or increased appetite. - Drowsiness or fatigue. - Hair loss or thinning. - Gastrointestinal upset. Serious or Rare Side Effects: - Hepatotoxicity or liver failure. - Acute pancreatitis. - Severe thrombocytopenia or blood dyscrasias. - Hyperammonemic encephalopathy. - Life‑threatening skin reactions (e.g., Stevens‑Johnson syndrome). - Birth defects when used in pregnancy.

What precautions apply to Sodium Valproate?

Before initiating therapy, consider the following precautions: - Pregnancy: Category D; avoid unless no suitable alternative exists. - Liver function: monitor hepatic enzymes regularly. - Blood counts: check platelet and white‑cell counts periodically. - Concomitant CNS depressants: use with caution due to additive sedation. - Alcohol: limit intake as it may increase toxicity. - Store at below 25°C: keep in the original pack, protect from moisture and direct sunlight.

What does Sodium Valproate interact with?

Major Interactions (Avoid): - Carbamazepine, phenytoin, phenobarbital: potent enzyme inducers that reduce valproate levels. - Aspirin or other NSAIDs: increase risk of hepatotoxicity. - Warfarin: may enhance anticoagulant effect and increase INR. Moderate Interactions (Monitor Closely): - Lamotrigine: risk of severe skin reactions; dose adjustments required. - Topiramate: may increase valproate concentrations. - Oral contraceptives: reduced efficacy of hormonal contraception. - Other antiepileptics (e.g., levetiracetam): monitor for additive CNS effects.

Frequently asked questions

What is Orfiril used for?+
Orfiril contains sodium valproate, an antiepileptic indicated for management of epilepsy, bipolar disorder, and migraine prophylaxis. It works by stabilizing neuronal firing and increasing GABA levels, helping reduce seizure activity, mood swings, and migraine frequency. The medication is prescribed by healthcare professionals based on individual patient needs and clinical assessment.
How does sodium valproate work?+
Sodium valproate increases the concentration of gamma‑aminobutyric acid (GABA) in the brain, an inhibitory neurotransmitter that reduces neuronal excitability. It also blocks voltage‑gated sodium channels, limiting rapid firing of neurons. These combined actions help control seizures, stabilize mood in bipolar disorder, and prevent migraine attacks by dampening abnormal electrical activity.
What is the usual dose of Orfiril?+
The dosage of Orfiril is individualized and determined by the prescribing clinician based on the specific condition, patient age, weight, and response to therapy. Typical dosing regimens for sodium valproate vary widely, and adjustments are made during treatment to achieve optimal therapeutic effect while minimizing adverse reactions. Patients should follow the prescriber’s instructions precisely.
Is Orfiril safe during pregnancy or breastfeeding?+
Sodium valproate is classified as Pregnancy Category D, indicating evidence of risk to the fetus, particularly neural‑tube defects, and it should be avoided unless no suitable alternative exists. Use during breastfeeding is also discouraged because the drug is excreted in breast milk and may affect the infant. Consultation with a healthcare provider is essential before use in these situations.
How do I order Orfiril from GNH USA?+
To request Orfiril, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams worldwide, and will ask for trade or institutional credentials. The sales team then provides pricing, availability, shipping details—including any necessary cold‑chain handling—and assists with import documentation.
How does Orfiril compare with other antiepileptic drugs?+
Compared with alternatives such as carbamazepine or lamotrigine, sodium valproate offers broad‑spectrum seizure control and is also effective for bipolar disorder and migraine prophylaxis. However, it carries a higher risk of hepatotoxicity, weight gain, and teratogenicity, especially in women of child‑bearing age. Choice of therapy depends on the patient’s clinical profile, comorbidities, and risk tolerance.
What are the storage requirements for Orfiril?+
Orfiril should be stored at below 25 °C (77 °F) in a dry place, protected from moisture and direct sunlight. Keep the product in its original container and ensure the lid is tightly closed. Do not freeze the tablets, and keep them out of reach of children. Proper storage helps maintain the medication’s stability and potency.
How is Orfiril administered?+
Orfiril is taken orally, usually with food or a glass of water to reduce gastrointestinal irritation. The tablet should be swallowed whole and not crushed, chewed, or broken unless specifically instructed by a healthcare professional. Consistency in timing and adherence to the prescribed schedule are important for maintaining stable drug levels and therapeutic effect.
What are the most serious risks associated with Orfiril?+
The most serious adverse effects of sodium valproate include liver failure, pancreatitis, severe thrombocytopenia, hyperammonemic encephalopathy, and birth defects when used during pregnancy. Patients should be monitored regularly for signs of hepatic dysfunction, abnormal blood counts, and neurological changes. Prompt medical attention is required if any severe symptoms develop.
Who should not use Orfiril?+
Orfiril is contraindicated in individuals with known hypersensitivity to sodium valproate or any of its excipients, those with severe hepatic disease, and patients with urea cycle disorders. It should also be avoided in pregnant women unless no alternative therapy is available, and in patients taking certain enzyme‑inducing anticonvulsants that may reduce its efficacy. A healthcare professional should evaluate suitability before prescribing.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Sodium Valproate
Route
Oral Use
Manufacturer
Desitin Arzneimittel Gmbh
Origin
EU

Related products

Absenor

Absenor

Sodium Valproate

Orion Corporation
EU
Absenor

Absenor

Sodium Valproate

Orion Corporation
EU
Absenor

Absenor

Sodium Valproate

Orion Corporation
EU
Absenor Depot

Absenor Depot

Sodium Valproate

Orion Corporation
EU